Reply: Vitamins B6 and B12, levodopa, and their complex interactions in patients with Parkinson's disease

Brain. 2022 Sep 14;145(9):e79-e80. doi: 10.1093/brain/awac248.

Authors

Ana Sardoeira¹, Nuno Vila-Chã¹, Marta Corrá^{1

2

3}, Ana Paula Sousa¹, Walter Maetzler⁴, Luís F Maia^{1

2

3}

Affiliations

¹ Department of Neurology, Centro Hospitalar Universitário do Porto (CHUPorto), 4099-001 Porto, Portugal.
² Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.
³ Institute for Research and Innovation in Health (i3s), University of Porto, 4200-135 Porto, Portugal.
⁴ Department of Neurology, Kiel University, 24118 Kiel, Germany.

PMID: 35802498
DOI: 10.1093/brain/awac248

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Levodopa* / therapeutic use
Parkinson Disease* / drug therapy
Pyridoxine
Vitamin B 6
Vitamins

Substances

Vitamins
Levodopa
Vitamin B 6
Pyridoxine